Form 4: ALX Oncology SVP, Finance and CAO, Shelly Pinto, Sells Shares to Cover Tax Obligations

Shelly Pinto, SVP, Finance and CAO of ALX Oncology Holdings Inc., sold 550 shares of common stock on February 19, 2025, to cover tax obligations related to vesting restricted stock units.

Summary

• On February 19, 2025, Shelly Pinto, the SVP, Finance and CAO of ALX Oncology Holdings Inc., sold 550 shares of common stock.
• The shares were sold at a weighted average price of $1.1502, with individual prices ranging from $1.15 to $1.16.
• The sale was executed to satisfy tax obligations related to the vesting of restricted stock units.
• Following the transaction, Pinto directly owns 87,352 shares of ALX Oncology Holdings Inc.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

This is a routine Form 4 filing, which is common for corporate insiders who sell shares of their company's stock. Often, these sales are related to covering tax obligations associated with stock-based compensation.

Stakeholder Impact

• The sale of shares by an insider could have a minor impact on shareholders, but is unlikely to be significant given the small number of shares involved.

Key Dates

Keywords

ALX Oncology Holdings Inc, ALXO, Shelly Pinto, Form 4, SEC Filing, Stock Sale, Insider Trading, Restricted Stock Units, Tax Obligations